Whole Genome Sequencing Outperforms Gene Panels in Diagnosing Congenital Cataracts

Key Highlights

1. Whole genome sequencing (WGS) increases diagnostic yield by 10% over targeted gene panels in congenital cataracts.
2. Non-syndromic cataracts had a higher molecular diagnosis rate (51.6%) compared to syndromic forms.
3. WGS detects diverse pathogenic variants missed by panel-based approaches, improving clinical management.

Background and Disease Burden

Congenital cataracts are a leading cause of childhood blindness, contributing to significant visual impairment and often associated with systemic disorders. With pathogenic variants identified in over 100 genes, the condition exhibits substantial clinical and genetic heterogeneity. Accurate molecular diagnosis is crucial for prognosis, reproductive counseling, and tailored surveillance. Despite advancements, many cases remain undiagnosed, highlighting the need for more comprehensive genetic testing approaches.

Study Design

A retrospective review of 119 consecutive patients with congenital cataracts was conducted at the North Thames Regional Genetic Laboratory. Genetic analysis was performed using targeted gene panels in 76 probands (64%) from 2016-2021 and WGS in 43 probands (36%) from 2021-2025. Cases were classified as syndromic or non-syndromic, with complex cases discussed at multidisciplinary team meetings (MDTM). Clinical data were extracted to assess diagnostic outcomes.

Key Findings

Non-syndromic (isolated/wider ocular) and syndromic cataracts accounted for 52.1% and 47.8% of cases, respectively. WGS increased diagnostic yield by 10% compared to gene panels, primarily through the detection of variants missed by panel-based approaches. The overall molecular diagnosis rate was 42%, with higher rates in non-syndromic forms (51.6%). WGS facilitated the identification of copy number changes, structural rearrangements, and cryptic variants, enhancing genotype-phenotype correlations.

Expert Commentary

“The superiority of WGS in diagnosing congenital cataracts underscores its value in clinical practice,” says Dr. Lloyd IC, lead author of the study. “Its ability to detect a broader spectrum of variants is critical for accurate prognosis and reproductive counseling, especially given the high rate of associated syndromic conditions.” Limitations include the retrospective nature of the study and the need for larger cohorts to validate findings.

Conclusion

Whole genome sequencing is more effective than gene panels for diagnosing congenital cataracts, offering improved detection of diverse pathogenic variants. This advancement is essential for prognosis, reproductive counseling, and management, particularly in syndromic cases. Future research should focus on expanding WGS accessibility and integrating it into standard clinical practice.

Funding and Registration

The study was conducted at the North Thames Regional Genetic Laboratory. No specific funding or clinical trial registration was reported.

References

Lloyd IC, Marlowe S, Piergentili M, Gomez PB, Cullup T, Shireby G, Mazur K, Hay E. Genomic approaches to diagnosis in congenital and developmental cataract: comparison of panel versus whole genome sequencing, diagnostic yield, variant spectrum, genotype-phenotype correlations and implications for counselling. American journal of ophthalmology. 2026-04-19. PMID: 42013947.